Senescence and Senolytics: How Clearing Senescent Cells Could Extend Your Healthspan

Accumulated senescent cells are now recognised as a key driver of age-related disease, and a new class of interventions is showing genuine promise in clearing them. Advance your understanding of the clinical evidence behind senolytics and what emerging therapeutic access means for Canadian practice. Take away specific solutions to:

• Master the mechanisms by which senescent cells accelerate biological aging and disease progression
• Evaluate the clinical evidence for leading senolytic interventions including dasatinib, quercetin and fisetin
• Identify where therapeutic access stands in Canada and how to stay ahead of a rapidly evolving field

Secure a sharper longevity strategy by applying the emerging science of cellular clearance to your practice.